Biotech startup Ukko picks up $40M
January 29, 2021- Share:
Leaps by Bayer has led a $40 million investment in biotech startup Ukko. The company, which has offices in Israel and Palo Alto, uses AI and protein engineering to develop food and therapies to treat food allergies. The capital will be used to fund clinical trials, focusing on peanut allergies.
Additional Investors
- Share:
-
-
-
-